Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma.


Journal

Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3231
Titre abrégé: Liver Int
Pays: United States
ID NLM: 101160857

Informations de publication

Date de publication:
05 2019
Historique:
received: 15 01 2019
revised: 10 02 2019
accepted: 25 02 2019
pubmed: 10 3 2019
medline: 16 1 2020
entrez: 10 3 2019
Statut: ppublish

Résumé

Human cholangiocarcinoma (CCA) is an aggressive tumour entity arising from the biliary tree, whose molecular pathogenesis remains largely undeciphered. Over the last decade, the advent of high-throughput and cell-based techniques has significantly increased our knowledge on the molecular mechanisms underlying this disease while, at the same time, unravelling CCA complexity. In particular, it becomes clear that CCA displays pronounced inter- and intratumoural heterogeneity, which is presumably the consequence of the interplay between distinct tissues and cells of origin, the underlying diseases, and the associated molecular alterations. To better characterize these events and to design novel and more effective therapeutic strategies, a number of CCA experimental and preclinical models have been developed and are currently generated. This review summarizes the current knowledge and understanding of these models, critically underlining their translational usefulness and limitations. Furthermore, this review aims to provide a comprehensive overview on cells of origin, cancers stem cells and their dynamic interplay within CCA tissue.

Identifiants

pubmed: 30851232
doi: 10.1111/liv.14094
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

79-97

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Silvestre Vicent (S)

Program in Solid Tumors, Center for Applied Applied Medical Research, University of Navarra, Pamplona, Spain.
IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Ruby Lieshout (R)

Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Anna Saborowski (A)

Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany.

Monique M A Verstegen (MMA)

Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Chiara Raggi (C)

Humanitas Clinical and Research Center, Rozzano, Italy.
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Stefania Recalcati (S)

Department of Biomedical Sciences for Health, University of Milan, Milano, Italy.

Pietro Invernizzi (P)

Division of Gastroenterology and Center of Autoimmune Liver Diseases, Department of Medicine and Surgery, San Gerardo Hospita, l, University of Milano, Bicocca, Italy.

Luc J W van der Laan (LJW)

Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Domenico Alvaro (D)

Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.

Diego F Calvisi (DF)

Institute of Pathology, University of Regensburg, Regensburg, Germany.

Vincenzo Cardinale (V)

Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH